整体外体序列测定在疑似患者中识别了GYS2双变异
Muhammad Ilyas1, Dorothea Holzwarth2, Rafaqat Ishaq3
1University Institute of Biochemistry and Biotechnology, Pir Mehr Ali Arid Agriculture University Rawalpindi, Pakistan; Department of Medical laboratory technology, Riphah International University, Malakand Campus, Pakistan; Department of Epileptology, University of Bonn, Germany.
Seizure
|August 13, 2023
概括
肝脏糖原合成酶基因 (GYS2) 的突变可能导致低血糖症,导致发作. 基因分析在两个家族中发现了GYS2变异,将这些突变与神经症状联系起来,并表明了类似发作的新原因.
科学领域:
- 遗传学 遗传学是一种遗传学.
- 神经学 神经学
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 葡萄糖对大脑功能至关重要;低血糖会引发发作.
- 通过GYS2调节的肝脏糖原合成,缓冲大脑的葡萄糖供应.
- 损伤的GYS2功能可能会导致神经问题.
研究的目的:
- 为了对两个有兄弟姐妹患有发作和低血糖症的家庭进行遗传特征.
- 为了确定GYS2基因中的突变作为这些症状的潜在原因.
主要方法:
- 在受影响的个体上进行了整体外体序列 (WES) 测序.
- 桑格测序证实了家族内的突变和分离.
- 收集了包括发作和血糖水平在内的表型数据.
主要成果:
- 鉴定出了三种GYS2基因突变,与自身逆性遗传相一致.
- 在一个家族中发现了一种同卵性拼接受体位变异.
- 在另一个家族中检测到两种新型化合物异合体变体,表明糖原储存障碍.
结论:
- 致病性GYS2变种可以导致低血糖,直接导致或影响发作.
- 被诊断为患者的发作可能源于GYS2基因突变.
- 管理包括饮食和药物调整改善了发作频率.
相关概念视频
Seizures: Classification
413
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
413
Genome-wide Association Studies-GWAS
13.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.6K
Antiepileptic Drugs: GABAergic Pathway Potentiators
461
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
461
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
346
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
346
Pleiotropy
40.6K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
40.6K


